Medicaid and Medicare

Section 303 (d) of the MMA (adobe pdf 26Kb) requires the implementation of a competitive acquisition program (CAP) for Medicare Part B drugs and biologicals not paid on a cost or prospective payment system basis. Beginning with drugs administered on or after January 1, 2006, physicians will be given a choice between buying and billing these drugs under the average sales price (ASP) system, or obtaining these drugs from vendors selected in a competitive bidding process.

Medicare Prescription Drug Coverage – “It’s all coming together”

Support Pelosi’s stand- demand preventive health care savings are included in the Affordable Health Choices Act

Comments are closed.